Laurie Marinaro-Pascale
Acute Care · Flemington, NJNPI 1598859936
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,387 of the $6,418 with a category attached, or 68.4%. 33 manufacturers reported payments, led by Medtronic at 58.1% of the total. Reporting peaked in 2023 at $3,224 and has fallen 74.9% since, to $808 in 2025. Among acute care clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $38.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Atricure, Inc.$379
- Boston Scientific$317
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$298
- Amgen$252
- E.r. Squibb & Sons, L.L.C.$152
- plus $1K from 27 others
What the payments were for
- Travel & lodging$2,03132%
- Food & beverage$4,38768%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 47 | $3,727 |
| Atricure, Inc. | 9 | $379 |
| Boston Scientific | 8 | $317 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $298 |
| Amgen | 16 | $252 |
| E.r. Squibb & Sons, L.L.C. | 4 | $152 |
| Johnson & Johnson | 7 | $146 |
| Infobionic, Inc | 1 | $134 |
| Novartis | 9 | $128 |
| Daiichi Sankyo Inc. | 6 | $98 |
| Kestra Medical Technology Services, Inc. | 3 | $90 |
| Merck | 6 | $87 |
| Novo Nordisk | 4 | $70 |
| Boehringer Ingelheim | 4 | $65 |
| AstraZeneca | 4 | $58 |
| Pfizer | 4 | $55 |
| Cleerly, Inc. | 2 | $41 |
| Baxter Healthcare | 1 | $29 |
| Philips North America LLC | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Esperion Therapeutics, Inc. | 2 | $25 |
| Altathera Pharmaceuticals LLC | 1 | $24 |
| Abiomed | 1 | $23 |
| Bayer | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Abbott | 1 | $16 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Medicomp Inc | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,418 in reported general payments places this provider in the 95th percentile of 656 acute care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 130 | $137,678 |
| XareltoRivaroxaban | 52 | $58,701 |
| EntrestoSacubitril/Valsartan | 19 | $15,403 |
| Metoprolol Succinate | 224 | $4,086 |
| Dofetilide | 19 | $2,894 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 75 | $1,752 |
| Midodrine Hcl | 33 | $1,586 |
| Flecainide Acetate | 28 | $1,267 |
| Diltiazem 24hr ErDiltiazem Hcl | 39 | $962 |
| Rosuvastatin Calcium | 47 | $917 |
| Atorvastatin Calcium | 88 | $897 |
| Amiodarone Hcl | 47 | $881 |
| Amlodipine Besylate | 113 | $844 |
| Carvedilol | 63 | $761 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 15 | $743 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $55 | $137,678130 claims |
| Johnson & JohnsonXarelto | $146 | $58,70152 claims |
| NovartisEntresto | $128 | $15,40319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 656 acute care providers in New Jersey.
Other acute care in Flemington
- Vincent FroncekFlemington$14K
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Ellen McCueNeptune$26K
- Suzanne ShuggLivingston$25K
- Maria Tedi CoronelHackensack$19K
- Hanane ChaibainouWestampton$16K
- Jennifer McCarthyNewark$16K
- Jennifer HarrarCamden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.